Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 124 record(s)

Req # A-2020-001599

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03352506.

Organization: Health Canada

11 page(s)
May 2021

Req # A-2020-001602

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03361608.

Organization: Health Canada

6 page(s)
May 2021

Req # A-2020-001627

Adverse Reaction Reports (AERs). Report numbers: E2B_03381172, E2B_03405398.

Organization: Health Canada

64 page(s)
May 2021

Req # A-2020-001631

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: 727178.

Organization: Health Canada

4 page(s)
May 2021

Req # A-2020-001639

Adverse Reaction Reports (AERs) for LEFLUNOMIDE. Report numbers: E2B_03262131, E2B_03262541, E2B_03238488, E2B_03262564, E2B_03264812, E2B_03265184, E2B_03266801, E2B_03267081, E2B_03267270, E2B_03267898, E2B_03269596, E2B_03269992, E2B_03271101, E2B_03271274, E2B_03275880, E2B_03276557, E2B_03276589.

Organization: Health Canada

603 page(s)
May 2021

Req # A-2020-001650

Adverse Reaction Reports (AERs) for FUROSEMIDE. Report numbers: 915058, 000916242, 000916876, 000919335, E2B_03174989, E2B_03210414, E2B_03234268, 000917022.

Organization: Health Canada

151 page(s)
May 2021

Req # A-2020-001652

Adverse Reaction Reports (AERs) for GLYCERYL TRINITRATE. Report numbers: E2B_03193921, E2B_03172074, E2B_03172067.

Organization: Health Canada

155 page(s)
May 2021

Req # A-2020-001675

Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_01198405.

Organization: Health Canada

64 page(s)
May 2021

Req # A-2020-001676

Adverse Drug Reaction (ADR) for PETHIDINE HYDROCHLORIDE. Report number: E2B_01198405.

Organization: Health Canada

64 page(s)
May 2021

Req # A-2020-001678

Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_01198405.

Organization: Health Canada

64 page(s)
May 2021
Date modified: